Surgery Partners Inc (SGRY) : Stonerise Capital Management scooped up 250,000 additional shares in Surgery Partners Inc during the most recent quarter end , the firm said in a disclosure report filed with the SEC on Aug 15, 2016. The investment management firm now holds a total of 650,000 shares of Surgery Partners Inc which is valued at $11,960,000.Surgery Partners Inc makes up approximately 5.74% of Stonerise Capital Management’s portfolio.
Other Hedge Funds, Including , Geode Capital Management boosted its stake in SGRY in the latest quarter, The investment management firm added 5,559 additional shares and now holds a total of 145,897 shares of Surgery Partners Inc which is valued at $2,684,505. Tfs Capital added SGRY to its portfolio by purchasing 23,436 company shares during the most recent quarter which is valued at $431,222. Surgery Partners Inc makes up approx 0.07% of Tfs Capital’s portfolio. Tower Research Capital (trc) sold out all of its stake in SGRY during the most recent quarter. The investment firm sold 300 shares of SGRY which is valued $5,520. Essex Investment Management Co added SGRY to its portfolio by purchasing 22,828 company shares during the most recent quarter which is valued at $412,730. Surgery Partners Inc makes up approx 0.07% of Essex Investment Management Co’s portfolio.
On the company’s financial health, Surgery Partners Inc reported $0.16 EPS for the quarter, beating the analyst consensus estimate by $ 0.02 according to the earnings call on Aug 9, 2016. Analyst had a consensus of $0.14. The company had revenue of $289.70 million for the quarter, compared to analysts expectations of $275.99 million. The company’s revenue was up 24.4% compared to the same quarter last year.
Many Wall Street Analysts have commented on Surgery Partners Inc. KeyBanc Capital Mkts Initiated Surgery Partners Inc on Jun 10, 2016 to “Overweight”, Price Target of the shares are set at $21.
Surgery Partners Inc. is a healthcare services company. The Company has differentiated outpatient delivery model focused on providing solutions for surgical and related ancillary care in support of its patients and physicians. It operates through three segments: Surgical Facility Services segment Ancillary Services segment and Optical Services segment. The Surgical Facility Services segment consists of the operation of ASCs and surgical hospitals and includes its anesthesia services. The Ancillary Services Segment consists of a diagnostic laboratory a specialty pharmacy and multi-specialty physician practices. The Optical Services Segment consists of an optical laboratory an optical products group purchasing organization and a marketing business. As of August 17 2015 the Company owned or operated primarily in partnership with physicians a portfolio of 99 surgical facilities which consist of 94 ambulatory surgery centers (ASCs) and five surgical hospitals across 28 states.